These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1569167)

  • 1. Effect of sodium restriction on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone, newly identified mineralocorticoids in man.
    Takeda Y; Miyamori I; Takeda R; Lewicka S; Vecsei P
    J Clin Endocrinol Metab; 1992 May; 74(5):1195-7. PubMed ID: 1569167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aging on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone.
    Takeda Y; Miyamori I; Yoneda T; Iki K; Takeda R
    J Steroid Biochem Mol Biol; 1995 Apr; 52(4):383-6. PubMed ID: 7734407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adrenocorticotropin stimulation on the synthesis of 19-noraldosterone in man.
    Takeda Y; Miyamori I; Yoneda T; Furukawa K; Hatakeyama H; Inaba S; Ito Y; Takeda R; Mabuchi H
    J Clin Endocrinol Metab; 1996 May; 81(5):1852-5. PubMed ID: 8626846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
    Takeda Y; Miyamori I; Iki K; Takeda R; Vecsei P
    Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of 19-noraldosterone, a new mineralocorticoid, in clinical and experimental hypertension.
    Takeda Y; Miyamori I; Takeda R
    Steroids; 1995 Jan; 60(1):137-42. PubMed ID: 7792799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 19-Noraldosterone in pregnancy-induced hypertension.
    Takeda Y; Yoneda T; Demura M; Furukawa K; Usukura M; Mabuchi H
    Steroids; 2002 Jun; 67(7):605-10. PubMed ID: 11996933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat and stroke-prone spontaneously hypertensive rat.
    Takeda Y; Miyamori I; Yoneda T; Hurukawa K; Inaba S; Ito Y; Takeda R
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S20-2. PubMed ID: 9072356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism.
    Takeda Y; Bige K; Iwuanyanwu T; Lewicka S; Vecsei P; Abdelhamid S; Harnik M
    Steroids; 1991 Nov; 56(11):566-70. PubMed ID: 1814024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 19-nor-aldosterone, 18-hydroxy-19-nor-corticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma.
    Takeda Y; Lewicka S; Koch S; Bige K; Vecsei P; Abdelhamid S; Cojocaru M; Harnik M
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):599-604. PubMed ID: 2278845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
    Kigoshi T; Iwasaki R; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthetic pathway of 19-noraldosterone in isolated rat glomerulosa cells.
    Takeda Y; Miyamori I; Iki K; Yoneda T; Takeda R
    J Steroid Biochem Mol Biol; 1994 May; 49(1):69-71. PubMed ID: 8003441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic adrenocorticotropin stimulation on the excretion of 18-hydroxycortisol and 18-oxocortisol.
    Gomez-Sanchez CE; Clore JN; Estep HL; Watlington CO
    J Clin Endocrinol Metab; 1988 Aug; 67(2):322-6. PubMed ID: 2839536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 18-hydroxy-19-norcorticosterone and 18-deoxy-19-noraldosterone. Structure determination of related 19-nor steroids by means of 2-D 1H nmr.
    Harnik M; Kashman Y; Carmely S; Cojocaru M; Dale SL; Holbrook MM; Melby JC
    Steroids; 1986 Jan; 47(1):67-81. PubMed ID: 3810700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
    Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI
    J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypertensinogenic activity of 18,19-dihydroxycorticosterone in adrenalectomized rats.
    Fragman S; Harnik M; Peleg E; Zamir N; Rosenthal T
    Am J Hypertens; 1992 Jun; 5(6 Pt 1):399-401. PubMed ID: 1524765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aging on renin activity and aldosterone excretion.
    Crane MG; Harris JJ
    J Lab Clin Med; 1976 Jun; 87(6):947-59. PubMed ID: 932525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 19-noraldosterone, a potent mineralocorticoid.
    Harnik M; Kashman Y; Cojocaru M; Rosenthal T; Morris DJ
    J Steroid Biochem; 1986 Jun; 24(6):1163-9. PubMed ID: 3736043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease.
    McQuarrie EP; Freel EM; Mark PB; Fraser R; Connell JM; Jardine AG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1526-32. PubMed ID: 23413088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary 18-hydroxycortisol and its relationship to the excretion of other adrenal steroids.
    Gomez-Sanchez CE; Upcavage RJ; Zager PG; Foecking MF; Holland OB; Ganguly A
    J Clin Endocrinol Metab; 1987 Aug; 65(2):310-4. PubMed ID: 3036905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
    Speckart P; Zia P; Zipser R; Horton R
    J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.